(Q43682865)

25 November 2017

CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability (English)

1 reference

25 November 2017

1 reference

T Kita

1

1 reference

25 November 2017

Y Tanigawara

2

1 reference

25 November 2017

N Aoyama

3

1 reference

25 November 2017

T Hohda

4

1 reference

25 November 2017

Y Saijoh

5

1 reference

25 November 2017

F Komada

6

1 reference

25 November 2017

T Sakaeda

7

1 reference

25 November 2017

K Okumura

8

1 reference

25 November 2017

T Sakai

9

1 reference

25 November 2017

M Kasuga

10

1 reference

25 November 2017

1 May 2001

1 reference

25 November 2017

Pharmaceutical Research

1 reference

25 November 2017

18

1 reference

25 November 2017

5

1 reference

25 November 2017

615-621

1 reference

Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents

25 November 2017

1 reference

12 December 2020

The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection

1 reference

12 December 2020

Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column

1 reference

12 December 2020

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

12 December 2020

CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori

1 reference

12 December 2020

Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori

1 reference

12 December 2020

Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori

1 reference

12 December 2020

Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers

1 reference

12 December 2020

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

12 December 2020

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

12 December 2020

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects

1 reference

12 December 2020

The life and death of Helicobacter pylori

1 reference

12 December 2020

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

1 reference

12 December 2020

A multifamily study on the relationship between CYP2C19 genotype and S-mephenytoin oxidation phenotype

1 reference

12 December 2020

Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.

1 reference

12 December 2020

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

1 reference

12 December 2020

A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer

1 reference

12 December 2020

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.

1 reference

12 December 2020

Molecular mechanisms of genetic polymorphisms of drug metabolism

1 reference

12 December 2020

Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population

1 reference

12 December 2020

Clinical pharmacology of omeprazole

1 reference

12 December 2020

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice

1 reference

12 December 2020

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

12 December 2020

Helicobacter pylori eradication: unravelling the facts.

1 reference

12 December 2020

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence

1 reference

12 December 2020

Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study

1 reference

12 December 2020

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

1 reference

12 December 2020

Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism

1 reference

12 December 2020

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

12 December 2020

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

12 December 2020

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011025125163

1 reference

25 November 2017

1 reference